Multimedia

In this video, Alice Gillams, MB, CHB, discusses the benefits of liver directed therapy. | View More
In this video, Constantino Peña, MD, discusses practical insights regarding radial access. | View More
Ziv Haskal, MD, introduces thyroid ablation, an important procedure that will increasingly be performed by interventional radiologists.  | View More
Bradford Wood, MD, explains recent changes to the field of prostate cancer and how they may affect interventional oncologists. | View More
Govindarajan Narayanan, MD, shares treatment techniques for drug-eluting embolics. | View More
Timothy Clark, MD, gives tips for conventional TACE in this Craftsman's Corner session from CIO. | View More
Adam D. Talenfeld, MD, is an attending physician at Weill Cornell Medical Center, New York Presbyterian Hospital in New York. At the 2016 Annual Scientific Meeting of the Society of Interventional Radiology, he presented data about percutaneous thermal ablation (PTA) vs surgery for small renal cancers. Here he shares some data and insights on the results. | View More
At the 2016 Annual Scientific Meeting of the Society of Interventional Radiology, Joseph Kallini, MD, clinical research fellow at Northwestern University, presented a value analysis using the 2015 American Society of Clinical Oncology framework comparing yttrium-90 radioembolization and transarterial chemoembolization. | View More
Interventional radiologists at Stanford University studied the effect of microwave ablation on portal vein and hepatic vein thrombosis in hepatocellular carcinoma and liver metastases and found the results to be encouraging for interventional oncology practice.  | View More
Riad Salem, MD, chief of interventional radiology at Northwestern University, spoke with Interventional Oncology 360 about results of a prospective randomized phase 2 study of chemoembolization versus radioembolization in hepatocellular carcinoma (the PREMIERE trial). | View More